Q2 2015 13F Holders as of 30 Jun 2015
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
2,911,968
-
Share change
-
+87,723
-
Total reported value
-
$6,522,000
-
Price per share
-
$2.24
-
Number of holders
-
15
-
Value change
-
+$187,401
-
Number of buys
-
11
-
Number of sells
-
4
Institutional Holders of CELATOR PHARMACEUTICALS INC - COM (CPXX) as of Q2 2015
As of 30 Jun 2015,
CELATOR PHARMACEUTICALS INC - COM (CPXX) was held by
15 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
2,911,968 shares.
The largest 10 holders included
CAXTON CORP, VANGUARD GROUP INC, CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM, BlackRock Fund Advisors, Nine Chapters Capital Management LLC, KCG Holdings, Inc., TFS CAPITAL LLC, BANK OF AMERICA CORP /DE/, Rotella Capital Management, Inc., and BlackRock Investment Management, LLC.
This page lists
15
institutional shareholders reporting positions in this security
for the Q2 2015 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.